Home
>
National Drug Code (NDC)
>
LIPTRUZET
LIPTRUZET - 66582-321-27 - (ezetimibe and atorvastatin)
Drug Information of LIPTRUZET
| Product NDC: | 66582-321 |
| Proprietary Name: | LIPTRUZET |
| Non Proprietary Name: | ezetimibe and atorvastatin |
| Active Ingredient(s): | 20; 10 mg/1; mg/1 & nbsp; ezetimibe and atorvastatin |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of LIPTRUZET
| Product NDC: | 66582-321 |
| Labeler Name: | Merck Sharp & Dohme Corp. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA200153 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20130503 |
Package Information of LIPTRUZET
| Package NDC: | 66582-321-27 |
| Package Description: | 4 POUCH in 1 CARTON (66582-321-27) > 1 BLISTER PACK in 1 POUCH (66582-321-11) > 7 TABLET, FILM COATED in 1 BLISTER PACK |
NDC Information of LIPTRUZET
| NDC Code | 66582-321-27 |
| Proprietary Name | LIPTRUZET |
| Package Description | 4 POUCH in 1 CARTON (66582-321-27) > 1 BLISTER PACK in 1 POUCH (66582-321-11) > 7 TABLET, FILM COATED in 1 BLISTER PACK |
| Product NDC | 66582-321 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | ezetimibe and atorvastatin |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20130503 |
| Marketing Category Name | NDA |
| Labeler Name | Merck Sharp & Dohme Corp. |
| Substance Name | ATORVASTATIN CALCIUM; EZETIMIBE |
| Strength Number | 20; 10 |
| Strength Unit | mg/1; mg/1 |
| Pharmaceutical Classes | Decreased Cholesterol Absorption [PE],Dietary Cholesterol Absorption Inhibitor [EPC],HMG-CoA Reductase Inhibitor [EPC],Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA] |
